Gastric neuroendocrine cells and secretory products.

Por Oberg, K.
Publicado em 1998

Biochemical diagnosis of neuroendocrine GEP tumor.

Por Oberg, K.
Publicado em 1997

Interferons in the management of neuroendocrine tumors and their possible mechanism of action.

Por Oberg, K.
Publicado em 1992

Expression and prognostic significance of Bcl-2 in ovarian tumours.

Por Henriksen, R., Wilander, E., Oberg, K.
Publicado em 1995

Transoesophageal echocardiography improves the diagnostic value of cardiac ultrasound in patients with carcinoid heart disease.

Por Lundin, L, Landelius, J, Andrén, B, Oberg, K
Publicado em 1990

Evaluation of the natural killer cell-interferon system in patients with mid-gut carcinoid tumours treated with leucocyte interferon.

Por Funa, K, Alm, G V, Rönnblom, L, Oberg, K
Publicado em 1983

Percutaneous ultrasonography-guided cutting biopsy from liver metastases of endocrine gastrointestinal tumors.

Por Andersson, T, Eriksson, B, Lindgren, P G, Wilander, E, Oberg, K
Publicado em 1987

Characterization of three peptides derived from prosomatostatin [prosomatostatin-(1-63)-, -(65-76)- and -(79-92)-peptides] in a human pancreatic tumour.

Por Conlon, J M, Eriksson, B, Grimelius, L, Oberg, K, Thim, L
Publicado em 1987

Secondary structures comparison of aquaporin-1 and bacteriorhodopsin: a Fourier transform infrared spectroscopy study of two-dimensional membrane crystals.

Por Cabiaux, V, Oberg, K A, Pancoska, P, Walz, T, Agre, P, Engel, A
Publicado em 1997

Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids

Por Granberg, D, Wilander, E, Stridsberg, M, Granerus, G, Skogseid, B, Oberg, K
Publicado em 1998

Characterization of anti-interferon-alpha antibodies appearing during recombinant interferon-alpha 2a treatment.

Por Rönnblom, L E, Janson, E T, Perers, A, Oberg, K E, Alm, G V
Publicado em 1992

Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease.

Por Waltenberger, J., Lundin, L., Oberg, K., Wilander, E., Miyazono, K., Heldin, C. H., Funa, K.
Publicado em 1993

Autoantibodies to epithelial cells in patients on long-term therapy with leucocyte-derived interferon-alpha (IFN-alpha).

Por Karlsson-Parra, A, Burman, P, Hagberg, H, Oberg, K, Alm, G, Klareskog, L, Karlsson, F A
Publicado em 1990

Localization of the MEN1 gene to a small region within chromosome 11q13 by deletion mapping in tumors.

Por Byström, C, Larsson, C, Blomberg, C, Sandelin, K, Falkmer, U, Skogseid, B, Oberg, K, Werner, S, Nordenskjöld, M
Publicado em 1990

The pentagastrin test in the diagnosis of the carcinoid syndrome. Blockade of gastrointestinal symptoms by ketanserin.

Por Ahlman, H, Dahlström, A, Grönstad, K, Tisell, L E, Oberg, K, Zinner, M J, Jaffe, B M
Publicado em 1985

Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival.

Por Norheim, I, Oberg, K, Theodorsson-Norheim, E, Lindgren, P G, Lundqvist, G, Magnusson, A, Wide, L, Wilander, E
Publicado em 1987

Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled pha...

Por Pavel, M.E., Baudin, E., Öberg, K.E., Hainsworth, J.D., Voi, M., Rouyrre, N., Peeters, M., Gross, D.J., Yao, J.C.
Publicado no Ann Oncol (2017)

Phase 3 Trial of (177)Lu-Dotatate for Midgut Neuroendocrine Tumors

Por Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P.L., Kulke, M.H., Jacene, H., Bushnell, D., O'Dorisio, T.M., Baum, R.P., Kulkarni, H.R., Caplin, M., Lebtahi, R., Hobday, T., Delpassand, E., Van Cutsem, E., Benson, A., Srirajaskanthan, R., Pavel, M., Mora, J., Berlin, J., Grande, E., Reed, N., Seregni, E., Öberg, K., Sierra, M. Lopera, Santoro, P., Thevenet, T., Erion, J.L., Ruszniewski, P., Kwekkeboom, D., Krenning, E.
Publicado no N Engl J Med (2017)